Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model

F. Liu, Q. Hong, C. Bai (Shanghai, China)

Source: Annual Congress 2013 –Basic research on lung cancer
Session: Basic research on lung cancer
Session type: Poster Discussion
Number: 3120
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Liu, Q. Hong, C. Bai (Shanghai, China). Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model. Eur Respir J 2013; 42: Suppl. 57, 3120

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An airway epithelial origin for tobacco carcinogen-induced lung adenocarcinoma
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015

Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015


Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


COPD-like inflammation drives the progression of K-ras induced early cancerous lesions
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

The role of lL-17 in the OVA-LPS driven model of lung inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015

Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015


LATE-BREAKING ABSTRACT: Osteopontin as an airway epithelial tumor promoter
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013

Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome in resected non-small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013

Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Cetuximab administered through pulmonary route in a mice model of lung tumor
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013


NRAS mutations destine tumor cells to the lungs
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015

Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Accelerated lung function decline increases the risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Tumor cell-derived osteopontin promotes lung metastasis via both cell-autonomous and paracrine pathways
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016